TScan Therapeutics Inc. (TCRX)

NASDAQ: TCRX · Real-Time Price · USD

1.60

0.05 (3.23%)

At close: May 02, 2025, 3:59 PM

1.55

-3.12%

After-hours: May 02, 2025, 05:26 PM EDT

TScan Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-127.5M	-89.22M	-66.22M	-48.63M	-26.13M	-13.66M
Depreciation & Amortization	4.11M	5.36M	5.14M	3.33M	1.23M	519K
Stock-Based Compensation	9.55M	5.21M	4.55M	2.52M	515K	240K
Other Working Capital	3.06M	17.66M	-10.76M	-5.91M	20.23M	138K
Other Non-Cash Items	-2.03M	-315K	260K	9.16M	2K	78K
Deferred Income Tax	n/a	n/a	n/a	-9.16M	n/a	n/a
Change in Working Capital	5.05M	17.61M	-10.23M	-5.9M	21.36M	299K
Operating Cash Flow	-110.82M	-61.36M	-66.5M	-48.68M	-3.02M	-12.52M
Capital Expenditures	-3.83M	-3.15M	-4.22M	-9.94M	-4.24M	-1.25M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-241.44M	-77.61M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	192.66M	20M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-52.61M	-60.76M	-4.22M	-9.94M	-4.24M	-1.25M
Debt Repayment	15.31M	n/a	29.35M	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	160.32M	93.03M	-191K	291K	288K	5K
Financial Cash Flow	208.76M	135.44M	29.36M	189.67M	288K	34.81M
Net Cash Flow	45.33M	13.33M	-41.37M	131.05M	-6.97M	21.04M
Free Cash Flow	-114.65M	-64.5M	-70.73M	-58.62M	-7.26M	-13.77M